Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...
FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...
BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands ...
The selection of BD Libertas™ Wearable Injector for this pharma-sponsored trial follows successful outcomes from more than 50 BD-conducted pre-clinical and clinical studies, including a device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results